MOBILion takes in $60m Series C
MOBILion Systems Inc, a provider of instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, has raised $60 million in Series C financing.
MOBILion Systems Inc, a provider of instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, has raised $60 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination